INGREZZA® (valbenazine) First Quarter Net Product Sales of $410 Million
INGREZZA® (valbenazine) 2023 Net Product Sales Guidance Reiterated at $1.67 - $1.77 Billion
Read more at prnewswire.comNeurocrine Biosciences Reports First Quarter 2023 Financial Results
Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.